HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Mr. Robert Eno 2023 'den beri şirketle birlikte olan Heartbeam Inc 'in Chief Executive Officer 'ıdır.
BEAT hissesinin fiyat performansı nasıl?
BEAT 'in mevcut fiyatı $1.21 'dir, son işlem günde 2.54% arttırılmış etti.
Heartbeam Inc için ana iş temaları veya sektörler nelerdir?
Heartbeam Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Heartbeam Inc 'in piyasa değerlemesi nedir?
Heartbeam Inc 'in mevcut piyasa değerlemesi $41.6M 'dir
Heartbeam Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 6 analist Heartbeam Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 4 al, 2 tut, 0 sat ve 2 güçlü sat içermektedir